A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART)

NCT03130712 PHASE1, PHASE2 UNKNOWN

In this study, CART cells are targeted to GPC3 by intratumor injected that we hope by this means could improve the local CAR-T cell numbers, meanwhile reduce the potential side effects.

Details

Lead sponsor	Shanghai GeneChem Co., Ltd.
Phase	PHASE1, PHASE2
Status	UNKNOWN
Enrolment	10
Start date	Sat Apr 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Mar 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Carcinoma, Hepatocellular

Interventions

• GPC3-CART cells

Countries

China